George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Hi Wheelie
It was 7p in late 2002. I remember it quite well because it was just after I married and my wife and I both set up equal portfolios of shares. Over the years her shares have generally done better than mine but GFM has been one of my successes thankfully!
I have emailed Lauren Williams at SAR’s IR email address re Peel Hunt 3 times in the last 10 days and not heard a whisper in response. Has she left or is she just rude. I don’t think expecting a reply to a long term and loyal investor in SAR from SAR’s Investor Relations is unreasonable.
Like you Mitty I got in in 2011 after the excitement of the mice trials .. sold 1/3 in July 2021 .. then topped up 2 weeks ago at 10p so hold more now than before but at a much lower average. A share price above £1 now would represent a sound investment anything above £2.50 would be brilliant anything above £5 would be stunning!!
I can see 10 buys at #30,000 or close! That’s certainly at least between a few and a lot.
A lot of #30,000 (or approx) this morning! Interesting pattern!
Already made a lot of money here .. in at 7p target price £1.50 but may hang on for £2 later this year. ARV is my hope moving forward!
The great thing now as well is owning a lot more shares than before because of the recent opportunity to buy at 10 to 12p!!
Totally agree Aber and others anything less than £250 million would be an insult but was just musing out loud that no one had tried! My target still remains a £billion the old Thoth target but would top slice on the way up.
One thing I don’t understand is why at the current ridiculous market cap of £11 million we have not been the subject of an opportunist hostile takeover bid? Surely big pharmas like GSK etc know all about SARs products and research and anything up to £25 million would just be small change to them for products with huge potential.
It has been a sorry tale since PH were appointed on 29 Oct 21 when the share price was £3.20; the consolidation, which was I guess, recommended by PH was on 4 Feb 22 when the share price £1.85; the calamitous RF funding, again I guess recommended by PH, was on 3 Aug 23 when the share price £0.97p. The price then fell to £0.10p. It has been absolutely shocking.
With right advice we could have raised significant funds at £1 or more quite easily in early 2022 and that is what the broker ie PH should have been recommending at that time. This could have helped fund us through 1801 P1 and 2 and most of 1802. Why didn’t they do that?
Thank goodness long term holders have come to help out this last week or so.
Onwards and upwards from here
Flooding predicted in the Arun valley tonight .. I’ll go out and test the waters!!
Prediction .. based on ?!!
Is it possible to compare buys with sells over last 5 trading days? It seems buys have massively exceeded sells but I didn’t make a note of actual figures each day so wonder if that information is available retrospectively?
It’s strange how the dynamics of the potential gain on SAR have changed. My ultimate target was always the original Thoth target of £14 which would have been a 23x gain on my original purchase price of 0.60 (1.2p old money). Having had the opportunity to significantly increase my holding at 0.10 I would only need £2.30 to get the 23x gain on those most recent purchases!
Surely the BoD would know of their broker was shorting their share and would take steps to either stop it or get rid of the broker; it hardly benefits the company to have its broker shorting its shares!
At the beginning of 2022 I seem to recall the share price was around £2 so raising £10 million at a £1 should have been possible.
We certainly could easily have raised £10 million in early 2022 that would have seen us through Phases 1 and most of 2. It is unforgivable that PH did not recommend or push that through.
Thanks guys. What I don’t get is how the 4 million shares that RF have been involved with, which was around 5% of our shares, could have had such a cataclysmic effect on the share price?
Is it possible to determine how much RF have lent us to date, how many shares RF have received, how many they have sold, how much we still owe them and when does it have to be repaid? Do we as shareholders have any rights to this information in the way that the public have with FOI requests? I wrote to IR on Wednesday requesting confirmation of the PH situation .. no reply to date.
Hi Potnak the problem I had as an accountant was getting enough information and appropriate reports to differentiate income from capital gains and in the end decided it wasn’t worth it!!
Frankly I would ban financial instruments generally that are too complicated for an averagely intelligent person to understand. I did Maths A level qualified as an accountant in 1979 but the hardest exam I ever sat was the Derivatives paper in my CISI investment manager exams 10 years ago; my daughter sat the same exam at the same time and completely agreed. I understand derivatives are meant to create stability but too often they do the opposite; there are plenty of examples from history of derivatives destabilising markets (Soros etc) and other financial products that even the heads of the financial companies didn’t understand (run up to 2008) .. this can’t be right. Bitcoin is something else entirely .. a ludicrous product so complicated that I refused to prepare tax returns for clients with crypto currencies on. The swings in the price of Crypto are completely ludicrous and they like derivatives and like subprime mortgages will sooner rather than later cause a financial crisis on the world stage .. no question!